- 201-500 Employees
- Based in Saint-Herblain, France
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; and DUKORAL, an oral vaccine for the prevention…More
Most Recent Responsibility Report
2022 Corporate Social Responsibility Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Valneva SE Sustainability Report, Valneva SE Corporate Social Responsibility Report, Valneva SE CSR Report, Valneva SE Corporate Responsibility, Valneva SE CR Report, Valneva SE Citizenship Report, Valneva SE ESG Report, and Valneva SE Environmental Report online.